Skip to main content



Local Cdiff information for Connecticut

Connecticut

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Connecticut.



Local Cdiff information for Connecticut

Connecticut

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Connecticut.

Providers

PAUL FEUERSTADT MD, FACG, AGAF

HAMDEN
2200 Whitney Avenue
Suite 330 & 360
Hamden, CT 06518
203-281-4463
203-287-2930 (fax)

MILFORD
40 Commerce Park
Milford, CT 06460
203-281-4463
203-287-2930 (fax)

Website

Regulation

C. diff Infections

Total Reported Cases: 900
Hospital Onset: 900
Community Onset: Not reported
Related Deaths: Not reported

Available Reports

Annual Progress based on SIR: 0.82
CDC STATE PROGRESS REPORT >
STATE REPORTING >

State Reporting Laws

Data Submission Required: Yes
Data Publicly Available: No
Data Validated: Yes
Facility-specific Data Publicly Reported: No
LTC Facility Submission Required: Yes
LTC Facility Data Publicly Reported: No
Law/Regulation: CGS, Section 19a-490, n-o
STATUTE >

State Contact

Richard Melchreit, MD
Coordinator, healthcare-associated Infections Program
Connecticut Department of Public Health
410 Capitol Avenue
P.O. Box 340308
Hartford, 6134
(860) 509-7833
EMAIL RICHARD MELCHREIT, MD >

CLINICAL TRIALS

FMT National Registry

Official Title: Fecal Microbiota Transplant National Registry
Trial No. NCT03325855
Type: Observational
Recruitment: Recruiting
Sponsor: American Gastroenterological Association
Contact: Sonya Serra, MSc
301-941-2616
EMAIL
Gender: All
Age: All ages

RESTORATiVE303

Official Title: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Trial No. NCT06237452
Type: Interventional
Recruitment: Recruiting
Sponsor: Vedanta Biosciences, Inc
Contact: Mary Garfield
EMAIL >
Gender: All
Age: 12 Years and older
Vedanta Biosciences has teamed up with Science37 to provide a site-less, decentralized approach. This means the study can be done remotely and the product comes to you, in your home. This allows applicants who are not near a study site or unable to travel to participate and receive treatment. You can sign up for the decentralized study here.

LMN-201

Official Title: A Phase 2, Randomized, Double-blind, Placebo-controlled Study of LMN-201 for Prevention of C. Difficile Infection Recurrence
Trial No. NCT05330182
Type: Interventional
Recruitment: Recruiting
Sponsor: Lumen Bioscience, Inc.
Contact: Carl Mason, MD
EMAIL >
Gender: All
Age: 18 Years and older

PRISM

Official Title: A Phase IIb, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of AZD5148 for Prevention of Recurrence of Clostridioides Difficile Infection in Individuals 18 Years of Age and Above
Trial No. NCT07285213
Type: Interventional
Recruitment: Recruiting
Sponsor: AstraZeneca
Contact: See trial website for site-specific contacts
Gender: All
Age: 18 Years and older